Emerging Therapies for Glioblastoma
Cancers · 12.04.2024 · 16 (8) · 1485
DOI: 10.3390/cancers16081485 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 12.04.2024. Verfasst von Stella Aimé Rios und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Biological and Chemical Sciences, College of Sciences, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIGMS, UTRGV Presidential Research Scholarships.
Abstract (Originalsprache)
Glioblastoma is most commonly a primary brain tumor and the utmost malignant one, with a survival rate of approximately 12–18 months. Glioblastoma is highly heterogeneous, demonstrating that different types of cells from the same tumor can manifest distinct gene expression patterns and biological behaviors. Conventional therapies such as temozolomide, radiation, and surgery have limitations. As of now, there is no cure for glioblastoma. Alternative treatment methods to eradicate glioblastoma are discussed in this review, including targeted therapies to PI3K, NFKβ, JAK-STAT, CK2, WNT, NOTCH, Hedgehog, and TGFβ pathways. The highly novel application of oncolytic viruses and nanomaterials in combating glioblastoma are also discussed. Despite scores of clinical trials for glioblastoma, the prognosis remains poor. Progress in breaching the blood–brain barrier with nanomaterials and novel avenues for targeted and combination treatments hold promise for the future development of efficacious glioblastoma therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Integrative Biological and Chemical Sciences, College of Sciences, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
ORCID-Profile: Stella Aimé Rios, Megan Keniry
Förderung
- NIGMS NIH HHS
- NIGMS
- UTRGV Presidential Research Scholarships
Zitieren
APA
Rios, S. A., Oyervides, S., Uribe, D., Reyes, A. M., Fanniel, V., Vazquez, J., & Keniry, M. (2024). Emerging Therapies for Glioblastoma. Cancers, 16(8), 1485. https://doi.org/10.3390/cancers16081485
Vancouver
Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J, et al. Emerging Therapies for Glioblastoma. Cancers. 2024;16(8):1485. doi:10.3390/cancers16081485
BibTeX
@article{Rios2024,
author = {Rios, Stella Aimé and Oyervides, Stephanie and Uribe, David and Reyes, Angelica Maree and Fanniel, Victor and Vazquez, Jonathan and Keniry, Megan},
title = {Emerging Therapies for Glioblastoma},
journal = {Cancers},
year = {2024},
volume = {16},
number = {8},
pages = {1485},
doi = {10.3390/cancers16081485}
}
EUVIMED